Paradigm Biopharmaceuticals Ltd (PBIGF)
0.19
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Paradigm Biopharmaceuticals Shareholders Equity (Quarterly): 35.53M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 35.53M |
| December 31, 2022 | 50.11M |
| June 30, 2022 | 29.11M |
| December 31, 2021 | 38.36M |
| June 30, 2021 | 58.81M |
| December 31, 2020 | 68.77M |
| June 30, 2020 | 74.33M |
| December 31, 2019 | 55.50M |
| Date | Value |
|---|---|
| June 30, 2019 | 57.99M |
| December 31, 2018 | 13.64M |
| June 30, 2018 | 10.18M |
| December 31, 2017 | 11.64M |
| June 30, 2017 | 10.29M |
| December 31, 2016 | 10.64M |
| June 30, 2016 | 8.386M |
| December 31, 2015 | 9.230M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
29.11M
Minimum
Jun 2022
74.33M
Maximum
Jun 2020
52.06M
Average
55.50M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | 26.42M |
| Kazia Therapeutics Ltd | 3.589M |
| Immutep Ltd | 22.88M |
| Opthea Ltd | -46.91M |
| Mesoblast Ltd | 501.84M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.40M |
| Total Liabilities (Quarterly) | 8.864M |
| Current Ratio | 4.891 |
| Net Debt Paydown Yield | 0.08% |